U.S. IPO Market in 2025: Revival in the Face of Caution and Complexity
After two years of subdued issuance, 2025 marks a pivotal moment for the U.S. IPO market. With increasing momentum in listings following a slow...
Cre8 Enterprise Ltd. (CRE) IPO: Singapore-Based Tech Service Provider Targets Nasdaq Initiation
The Singapore-based company Cre8 Enterprise Ltd., specializing in technology services, plans to access U.S. capital markets through an IPO on the Nasdaq Capital Market under the ticker CRE....
Figma, Inc. (FIG) Files for IPO on NYSE Amid Soaring Demand for Digital Design Tools
IPO Overview: Figma Seeks to Raise $100 Million
Figma, Inc., the collaborative design platform used by some of the world’s leading tech brands, has officially...
New SPAC on the Block: Drugs Made In America Acquisition II Files for $500M IPO Amid Pharma Nationalization Push
Fort Lauderdale, FL | July 21, 2025 —
In a bold bet on the reshoring of American pharmaceutical manufacturing, Drugs Made In America Acquisition II Corp (Nasdaq: DMIIU) filed...
Figma Files for $1 Billion IPO Amid Soaring Growth and Strategic Reset
Design platform eyes $16.4 billion valuation as it steps into public markets post-Adobe deal collapse
Figma, the browser-based collaborative design platform, has officially filed terms...
